Two high-throughput screening assays for aberrant RNA–protein interactions in myotonic dystrophy type 1
Catherine Z. Chen(National Institutes of Health), Christopher P. Austin(Unknown), Noel Southall(National Institutes of Health), Charles A. Thornton(University of Rochester Medical Center), Wei Zheng(Liaoning Cancer Hospital & Institute), Juan Marugán(National Institutes of Health), Krzysztof Sobczak(Adam Mickiewicz University in Poznań), Jason W. Hoskins(University of Rochester)
Cited by 66
Related Papers
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848
Identification of the gene responsible for Best macular dystrophy
|Nature Genetics|1998|685